Thomas Flaten
Stock Analyst at Lake Street
(1.95)
# 3,032
Out of 4,941 analysts
29
Total ratings
36.67%
Success rate
-3.78%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $7.25 | +79.43% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $2.89 | +177.30% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $5.66 | +147.35% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.30 | +247.83% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $3 → $2 | $0.42 | +380.19% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $19.31 | +81.25% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $3.90 | +105.13% | 2 | Mar 7, 2025 | |
| EVAX Evaxion | Maintains: Buy | $35 → $6 | $2.90 | +106.90% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $4.76 | +89.08% | 2 | Jan 8, 2025 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.83 | +259.54% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $2.53 | +334.78% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $24.68 | +1.30% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.12 | +67,712.57% | 2 | Nov 17, 2022 |
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $7.25
Upside: +79.43%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $2.89
Upside: +177.30%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $5.66
Upside: +147.35%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.30
Upside: +247.83%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.42
Upside: +380.19%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $19.31
Upside: +81.25%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.90
Upside: +105.13%
Evaxion
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $2.90
Upside: +106.90%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $4.76
Upside: +89.08%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.83
Upside: +259.54%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.53
Upside: +334.78%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $24.68
Upside: +1.30%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.12
Upside: +67,712.57%